Abbott Laboratories (ABT) Stock Price, Quote, News & History

Q: What sector and industry does Abbott Laboratories (ABT) operate in?

Abbott Laboratories is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.

Comments

Abbott Laboratories (ABT) Stock Price, Quote, News & History

ABTNYSE

Trade with Public

$112.28

1.211.09%

At close: Feb 10, 4:00 PM EST

$112.50

0.220.20%

After Hours: 4:34 PM EST

Overview

News Earnings Options Guidance Dividends Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Key Statistics

Open

$111.18

Close

$112.28

Volume / Avg.

10.51M / 8.65M

Day Range

$111.00 - $112.75

52 Wk Range

105.27 - 141.23

Market Cap

$195.62B

P/E Ratio

29.86

Dividend Yield

2.27%

Exchange

NYSE

RSI

44

Short Interest

1.15%

Days to Cover

3.31

Recent Abbott Laboratories News

DraftKings, Abbott, And Applovin Are Among Top 10 Large Cap Losers Last Week (Jan. 19-Jan. 23): Are the Others in Your Portfolio?

Last week's biggest large-cap decliners included AeroVironment, DraftKings, AppLovin and Abbott, pressured by news, earnings and analyst actions.

Nabaparna Bhattacharya

Abbott's India Unit Under Scrutiny Due To Phensedyl Cough Syrup Supply Chain

Indian authorities probe Abbott Healthcare's Phensedyl supply chain as documents flag excess sales and alleged diversion.

Vandana Singh

Tesla To $360? Here Are 10 Top Analyst Forecasts For Friday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

9.12B

Investing Cash Flow (TTM)

-2.38B

Financing Cash Flow (TTM)

-6.77B

Free Cash Flow (TTM)

6.92B

Capital Expenditure (TTM)

-2.20B

Net Change in Cash (TTM)

-29.00M

Analyst Trends and Forecast

8

Oct 25

1

Nov 25

9

Jan

1

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$197.93B

PE Ratio (TTM)

29.86

PE Ratio (FWD)

19.57

PEG Ratio (TTM)

-

PS Ratio (TTM)

4.38

PB Ratio (TTM)

3.79

Earnings Yield % (TTM)

3.35%

Earnings Yield % (FWD)

5.11%

EV / EBITDA (TTM)

19.20

Price / EBITDA (TTM)

18.80

Price / Free Cash Flow (TTM)

28.08

Book Value / Share

$29.30

Company Debt

Total Debt

$12.94B

LT Debt

$11.60B

LT Debt Issuance (TTM)

$4.00M

LT Debt Repayment (TTM)

-$2.14B

Total Cash

$7.51B

Debt to Equity

-

Issuance of Debt (TTM)

-$2.14B

Repayment of Debt (TTM)

-$2.14B

Key Statistics

Open

$111.18

Close

$112.28

Volume / Avg.

10.51M / 8.65M

Day Range

$111.00 - $112.75

52 Wk Range

105.27 - 141.23

Market Cap

$195.62B

P/E Ratio

29.86

Dividend Yield

2.27%

Exchange

NYSE

RSI

44

Short Interest

1.15%

Days to Cover

3.31

About

Sector

Health Care

Industry

Health Care Equipment & Supplies

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neu...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy Abbott Laboratories (ABT) stock?

A

You can purchase shares of Abbott Laboratories (NYSE:ABT) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Abbott Laboratories (ABT) competitors?

A

Other companies in Abbott Laboratories’s space includes: Steris PLC (NYSE:STE), Masimo Corp (NASDAQ:MASI), Envista Holdings Corp (NYSE:NVST), Koninklijke Philips NV (NYSE:PHG) and Smith & Nephew PLC (NYSE:SNN).

Q

What is the forecast, or price target, for Abbott Laboratories (ABT) stock?

A

Abbott Laboratories has a consensus price target of $139.67.

Q

What is the current price for Abbott Laboratories (ABT)?

A

The stock price for Abbott Laboratories (NYSE: ABT) is $112.5 last updated February 10, 2026 at 4:34 PM EST.

Q

Does Abbott Laboratories (ABT) pay a dividend?

A

There are no upcoming dividends for Abbott Laboratories.

Q

When is Abbott Laboratories (NYSE:ABT) reporting earnings?

A

Abbott Laboratories does not have any upcoming earnings scheduled.

Q

Is Abbott Laboratories (ABT) going to split?

A

There is no upcoming split for Abbott Laboratories.

Q

What sector and industry does Abbott Laboratories (ABT) operate in?

A

Abbott Laboratories is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.

People Also Watch

Envista Holdings Corp

NYSE:NVST

$29.58

-1.99%

Koninklijke Philips NV

Becton Dickinson & Co

Key Statistics

Open

$111.18

Close

$112.28

Volume / Avg.

10.51M / 8.65M

Day Range

$111.00 - $112.75

52 Wk Range

105.27 - 141.23

Market Cap

$195.62B

P/E Ratio

29.86

Dividend Yield

2.27%

Exchange

NYSE

RSI

44

Short Interest

1.15%

Days to Cover

3.31

Recent Abbott Laboratories News

DraftKings, Abbott, And Applovin Are Among Top 10 Large Cap Losers Last Week (Jan. 19-Jan. 23): Are the Others in Your Portfolio?

Last week's biggest large-cap decliners included AeroVironment, DraftKings, AppLovin and Abbott, pressured by news, earnings and analyst actions.

Nabaparna Bhattacharya

Abbott's India Unit Under Scrutiny Due To Phensedyl Cough Syrup Supply Chain

Indian authorities probe Abbott Healthcare's Phensedyl supply chain as documents flag excess sales and alleged diversion.

Vandana Singh

Tesla To $360? Here Are 10 Top Analyst Forecasts For Friday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

9.12B

Investing Cash Flow (TTM)

-2.38B

Financing Cash Flow (TTM)

-6.77B

Free Cash Flow (TTM)

6.92B

Capital Expenditure (TTM)

-2.20B

Net Change in Cash (TTM)

-29.00M

Analyst Trends and Forecast

8

Oct 25

1

Nov 25

9

Jan

1

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$197.93B

PE Ratio (TTM)

29.86

PE Ratio (FWD)

19.57

PEG Ratio (TTM)

-

PS Ratio (TTM)

4.38

PB Ratio (TTM)

3.79

Earnings Yield % (TTM)

3.35%

Earnings Yield % (FWD)

5.11%

EV / EBITDA (TTM)

19.20

Price / EBITDA (TTM)

18.80

Price / Free Cash Flow (TTM)

28.08

Book Value / Share

$29.30

Company Debt

Total Debt

$12.94B

LT Debt

$11.60B

LT Debt Issuance (TTM)

$4.00M

LT Debt Repayment (TTM)

-$2.14B

Total Cash

$7.51B

Debt to Equity

-

Issuance of Debt (TTM)

-$2.14B

Repayment of Debt (TTM)

-$2.14B

Key Statistics

Open

$111.18

Close

$112.28

Volume / Avg.

10.51M / 8.65M

Day Range

$111.00 - $112.75

52 Wk Range

105.27 - 141.23

Market Cap

$195.62B

P/E Ratio

29.86

Dividend Yield

2.27%

Exchange

NYSE

RSI

44

Short Interest

1.15%

Days to Cover

3.31

About

Sector

Health Care

Industry

Health Care Equipment & Supplies

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neu...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry